Amniotic membrane or amnion is a thin membrane in inner side of placenta. Amniotic membrane has different thickness from 0.02 mm to 0.5 mm and consists in three different layer epithelial layer, thick basement membrane and avascular mesenchymal tissue. Amniotic membrane has multiple functions such as delivery of water and soluble materials and production of bioactive factors.
Increasing incidences of chronic diseases such as cancer among individuals, use of amniotic membrane to restrict growth of cancer cells is a major factor driving growth of the global amniotic membrane market. In addition, pluripotent properties of amniotic membrane cells and other characteristics such as anti-viral, immunological, anti-inflammatory, and anti-bacterial demand from special clinics, research centers and laboratories is expected to boost growth of the global amniotic membrane market.
Moreover, use of amniotic membrane in skin applications and other surgical procedures is expected to support growth of the global amniotic membrane market. However, high cost of treatment is a major factor restraining growth of the global amniotic membrane market. In addition, death of professionals in health care sector may challenge growth of the market.
The global amniotic membrane market report has been segmented on the basis of application, and region.
Do Inquiry of the Report Here: https://marketresearch.biz/report/amniotic-membrane-market/#inquiry
On the basis of type, the market is segmented into cryopreservation amniotic membrane and lyophilized amniotic membrane. On the basis of application, the market is segmented into Surgical wound, ophthalmology, and others. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key players operating in the global amniotic membrane market include Derma Sciences Inc., FzioMed, Inc., Alliqua BioMedical, Skye Biologics Inc., Amniox Medical, Inc., MiMedx Group, Inc., Human Regenerative Technologies, LLC, Tissue-Tech Inc., Applied Biologics LLC, and Amnio Technology, LLC.